Condition: Parenteral Nutrition · Sponsor: Yuhan Corporation
A Randomized, Open-labeled, Multi-center, Active-controlled, Parallel-group Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of NTCB02-1 versus NTCB-C in patients who require parenteral nutrition
This description comes directly from the study's public registry record.
Jinhyun Choi · 8228280850 · clinicaltrials@yuhan.co.kr
Always discuss trial participation with your own doctor first.
| National Cancer Center | Gyeonggi-do, Goyang-si, South Korea | Recruiting |
| Chonnam National University Hwasun Hospital | Jeollanam-do, Hwasun-gun, South Korea | Recruiting |
| Jeonbuk National University Hospital | Jeollabuk-do, Jeonju-si, South Korea | Recruiting |
| Severance Hospital | Seoul, Seodaemun-gu, South Korea | Recruiting |
| Seoul National University Bundang | Gyeonggi-do, Seongnam-si, South Korea | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06625957